Ignite Creation Date:
2025-12-24 @ 1:18 PM
Ignite Modification Date:
2026-04-07 @ 12:10 AM
Study NCT ID:
NCT00148395
Status:
COMPLETED
Last Update Posted:
2008-04-22
First Post:
2005-09-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Randomized Phase III-Study in Stage IIIb and IV Non-Small-Cell Lung Cancer. Sequential Single-Agent vs. Double-Agent vs. Triple-Agent Therapy.
Sponsor:
Aktion Bronchialkarzinom e.V.
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
NSCLC 06/2001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None